Further studies involving various thyroid cancer-derived cell lines are imperative to validate the functional interplay among ATF3, mutant p53, TAp63, ΔNp63, and SHARP1 and their significance in conferring drug resistance in TCs. Here, TP53 is linked to thyroid gland carcinoma.